Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.

Br J Cancer · 1993 · PMC1968306 · PMID 8318424

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

of borderline significanceP = 0.07so close (0.05 < p ≤ 0.1)

The change of the hybride constant A, representing the distribution phase, in fact, was of borderline significance (P = 0.07).

also in 1,254 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.